Scientists hunt for clues in melanoma tumors and blood

NCT ID NCT04567706

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects blood and tumor samples from 1,000 people with melanoma and healthy volunteers. Researchers will analyze these samples to learn more about what causes melanoma and how tumors behave. The goal is to find new markers that could lead to better diagnosis or treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could uncover new markers or targets that may eventually lead to better diagnosis or treatment for melanoma.
What could go wrong
This is an observational sample-collection study, not a treatment trial. It does not directly test any therapy, so any future benefits are uncertain and far off.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.